Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000723744 | SCV000112530 | uncertain significance | not provided | 2013-10-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000553672 | SCV000625906 | likely benign | Duchenne muscular dystrophy | 2024-02-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000080628 | SCV000723165 | likely benign | not specified | 2017-09-22 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV004019556 | SCV004856037 | uncertain significance | Cardiovascular phenotype | 2022-09-19 | criteria provided, single submitter | clinical testing | The c.4775T>C (p.M1592T) alteration is located in exon 34 (coding exon 34) of the DMD gene. This alteration results from a T to C substitution at nucleotide position 4775, causing the methionine (M) at amino acid position 1592 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |